Literature DB >> 8501558

Pediatric infective endocarditis in the modern era.

L Saiman1, A Prince, W M Gersony.   

Abstract

Sixty-two cases of endocarditis occurring in children between January 1977 and February 1992 were reviewed and compared with series from the 1970s and early 1980s. Changes in risk factors, pathogens, diagnostic modalities, and outcome were determined. Complex congenital heart disease (22 cases) and unrepaired ventricular septal defect (9 cases) were the most common underlying lesions. A total of 19 children with normal anatomy had endocarditis; 6 had community-acquired infection and 13 had hospital-acquired endocarditis (11 of these 13 children had central venous catheters in place, including 7 premature infants). Echocardiograms revealed vegetations in 25 of 49 patients; 24 of these patients had positive echocardiographic findings on the first study. Echocardiographic findings were most often negative in children with complex cyanotic heart disease. Staphylococcus aureus (39%) was the most common pathogen isolated and was associated with a higher incidence of central nervous system complications (p < 0.0015) and a greater need for surgical intervention (p = 0.01) than were other pathogens. Methicillin-resistant S. aureus (eight cases) and coagulase-negative staphylococci (three cases) emerged as important pathogens but were not associated with increased morbidity or mortality rates. Fungal endocarditis (six cases) had a 67% mortality rate. Overall the mortality rate was 11%. Endocarditis remained undiagnosed in seven seriously ill patients until postmortem examination. This study indicates that, during the past decade, important changes in risk factors, pathogens, and the susceptible population have altered the presentation and management of endocarditis in children.

Entities:  

Mesh:

Year:  1993        PMID: 8501558     DOI: 10.1016/s0022-3476(09)90006-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  22 in total

1.  Urgent homograft aortic root replacement for aortic root abscess in infants and children.

Authors:  R Chaturvedi; M de Leval; I D Sullivan
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

2.  Endocarditis in the Pediatric Population.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-12

3.  Echocardiography for the Diagnosis of Staphylococcus aureus Infective Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

4.  Fungal endocarditis.

Authors:  George M Varghese; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

Review 5.  18F-FDG-PET/CT Angiography for the Diagnosis of Infective Endocarditis.

Authors:  A Roque; M N Pizzi; H Cuéllar-Calàbria; S Aguadé-Bruix
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

6.  Group B streptococcal endocarditis in infancy with a giant vegetation on the pulmonary valve.

Authors:  H Horigome; Y Okada; T Hirano; M Tsuchida; S Ohtani; T Yoshimura
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

7.  Dental prevention and disease awareness in children with congenital heart disease.

Authors:  Steffen Koerdt; Julia Hartz; Stefan Hollatz; Gesche Frohwitter; Marco R Kesting; Peter Ewert; Renate Oberhoffer; Herbert Deppe
Journal:  Clin Oral Investig       Date:  2017-10-16       Impact factor: 3.573

8.  Pediatric infective endocarditis: Has Staphylococcus aureus overtaken viridans group streptococci as the predominant etiological agent?

Authors:  Aisha Alshammary; Marilou Hervas-Malo; Joan L Robinson
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

9.  [Description of 8 cases with gonadal dysgenesis syndrome type 46XY].

Authors:  E Deligeoroglou; P Fotaki; D Kokkalis; G Creatsas
Journal:  Akush Ginekol (Sofiia)       Date:  2001

10.  Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years.

Authors:  C C Lamas; S J Eykyn
Journal:  Heart       Date:  1998-05       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.